964 related articles for article (PubMed ID: 808500)
1. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
Svennerholm AM
Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
[TBL] [Abstract][Full Text] [Related]
2. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
Friedman H
Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae.
Holmgren J; Svennerholm AM; Ouchterlony O
Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):489-96. PubMed ID: 4509186
[No Abstract] [Full Text] [Related]
6. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
[TBL] [Abstract][Full Text] [Related]
7. B-cell responses to lipopolysaccharide epitopes: Who sees what first - does it matter?
Wade WF
Am J Reprod Immunol; 2006; 56(5-6):329-36. PubMed ID: 17076677
[TBL] [Abstract][Full Text] [Related]
8. Cholera antibody response in immunized persons in a cholera free area. II. Vibriocidal antibodies.
Chirescu N; Năcescu N; Ciufecu C
Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):149-53. PubMed ID: 4412422
[No Abstract] [Full Text] [Related]
9. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
10. A one dose experimental cholera vaccine.
Muse M; Grandjean C; Wade TK; Wade WF
FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
[TBL] [Abstract][Full Text] [Related]
11. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
[TBL] [Abstract][Full Text] [Related]
12. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.
Wade TK; Wade WF
Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975
[TBL] [Abstract][Full Text] [Related]
13. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
Chaicumpa W; Atthasisiha N
Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
[TBL] [Abstract][Full Text] [Related]
14. Protection against mortality due to Vibrio cholerae infection in infant rabbits caused by immunization of mothers with cholera protective antigen.
Sciortino CV
J Diarrhoeal Dis Res; 1996 Mar; 14(1):16-26. PubMed ID: 8708328
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
[TBL] [Abstract][Full Text] [Related]
16. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
18. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
Chaicumpa W; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
[TBL] [Abstract][Full Text] [Related]
19. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
Nygren E; Holmgren J; Attridge SR
Vaccine; 2008 Dec; 26(52):6784-90. PubMed ID: 18951939
[TBL] [Abstract][Full Text] [Related]
20. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
